Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.42 - $1.48 $219 - $772
522 New
522 $1,000
Q4 2020

Feb 12, 2021

SELL
$10.34 - $13.77 $9,667 - $12,874
-935 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$11.73 - $16.25 $29,583 - $40,982
-2,522 Reduced 72.95%
935 $11,000
Q2 2020

Aug 13, 2020

SELL
$13.68 - $20.46 $1.36 Million - $2.04 Million
-99,658 Reduced 96.65%
3,457 $56,000
Q1 2020

May 13, 2020

BUY
$14.83 - $26.72 $1.11 Million - $2 Million
74,936 Added 265.93%
103,115 $1.6 Million
Q4 2019

Feb 14, 2020

BUY
$9.77 - $24.6 $269,808 - $679,353
27,616 Added 4905.15%
28,179 $693,000
Q3 2019

Nov 14, 2019

SELL
$10.17 - $13.86 $560,946 - $764,476
-55,157 Reduced 98.99%
563 $6,000
Q2 2019

Aug 14, 2019

BUY
$11.43 - $15.12 $628,009 - $830,753
54,944 Added 7080.41%
55,720 $699,000
Q1 2019

May 10, 2019

BUY
$5.98 - $13.98 $41 - $97
7 Added 0.91%
776 $10,000
Q4 2018

Feb 13, 2019

SELL
$5.22 - $10.44 $1,884 - $3,768
-361 Reduced 31.95%
769 $4,000
Q3 2018

Nov 13, 2018

SELL
$9.5 - $13.75 $752,666 - $1.09 Million
-79,228 Reduced 98.59%
1,130 $12,000
Q2 2018

Aug 10, 2018

BUY
$12.85 - $18.45 $708,484 - $1.02 Million
55,135 Added 218.59%
80,358 $1.09 Million
Q1 2018

May 09, 2018

BUY
$12.5 - $19.75 $285,300 - $450,774
22,824 Added 951.4%
25,223 $448,000
Q4 2017

Feb 14, 2018

SELL
$11.55 - $20.1 $469,172 - $816,482
-40,621 Reduced 94.42%
2,399 $0
Q3 2017

Nov 13, 2017

BUY
$12.7 - $19.25 $546,354 - $828,135
43,020
43,020 $820,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.